LYELL IMMUNOPHARMA INC's ticker is LYEL and the CUSIP is 55083R104. A total of 76 filers reported holding LYELL IMMUNOPHARMA INC in Q2 2022. The put-call ratio across all filers is - and the average weighting 1.6%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $1,070,302 | -31.3% | 728,097 | +48.5% | 0.00% | – |
| Q2 2023 | $1,558,925 | -10.6% | 490,228 | -33.6% | 0.00% | – |
| Q1 2023 | $1,743,551 | -21.8% | 738,793 | +15.0% | 0.00% | – |
| Q4 2022 | $2,229,396 | +21.8% | 642,477 | +157.1% | 0.00% | – |
| Q3 2022 | $1,831,000 | +82.2% | 249,853 | +62.1% | 0.00% | – |
| Q2 2022 | $1,005,000 | +6.6% | 154,173 | -17.5% | 0.00% | – |
| Q1 2022 | $943,000 | +39.7% | 186,837 | +114.4% | 0.00% | – |
| Q4 2021 | $675,000 | +2150.0% | 87,164 | +4187.5% | 0.00% | – |
| Q3 2021 | $30,000 | -97.1% | 2,033 | -96.8% | 0.00% | – |
| Q2 2021 | $1,046,000 | – | 64,460 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| MWG Management Ltd. | 20,162,332 | $131,458,000 | 59.13% |
| Apoletto Ltd | 15,093,969 | $98,413,000 | 27.22% |
| Foresite Capital Management IV, LLC | 13,282,181 | $86,600,000 | 23.32% |
| MIC Capital Management UK LLP | 3,060,569 | $19,955,000 | 3.90% |
| Alphabet Inc. | 5,865,125 | $38,241,000 | 2.08% |
| HSG Holding Ltd | 3,045,997 | $19,860,000 | 1.83% |
| Board of Trustees of The Leland Stanford Junior University | 1,647,882 | $10,744,000 | 0.72% |
| SG3 Management, LLC | 600,000 | $3,912,000 | 0.46% |
| KETTLE HILL CAPITAL MANAGEMENT, LLC | 157,700 | $1,028,000 | 0.26% |
| Artal Group S.A. | 700,000 | $4,564,000 | 0.24% |